This was the first prospective study to assess the safety and efficiency of MynxGrip vascular closure device (VCD) in peripheral interventions with antegrade access.
Methods and Results:
We enrolled 66 consecutive patients from 1 center. All patients were discharged home on the day of procedure and were observed for adverse events at 1 and 30 days of follow-up. No major complications were observed. The rate of minor complications (conversion to manual or mechanical compression) was 7.6%. Postdischarge, 3% of patients experienced minor complications—small abscess, ipsilateral deep vein thrombosis. In 1 patient, a second VCD was deployed after device failure. The derived device failure rate was 5.9%. No patients required hospitalization. No late bleeding and no hematomas >6 cm were noted. The mean time to discharge was 4 hours and 5 minutes.
Conclusion:
The MynxGrip was safe and effective in sealing access sites after antegrade femoral artery puncture with same-day discharge.
NorgrenLHiattWRDormandyJANehlerMRHarrisKAFowkesFG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5–S67.
2.
DeRubertisBGFariesPLMcKinseyJF. Shifting paradigms in the treatment of lower extremity vascular disease. A report of 1000 percutaneous interventions. Ann Surg. 2007;246(3):415–422.
3.
SherevDAShawREBrentBN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv. 2005;65(2):196–202.
4.
KikkertWJDelewiROuweneelDM. Prognostic value of access site and nonaccess site bleeding after percutaneous coronary intervention: a cohort study in ST-segment elevation myocardial infarction and comprehensive meta-analysis. JACC Cardiovasc Interv. 2014;7(6):622–630.
5.
HeldeSGewaltSIbrahimT. Gender specific analysis of the randomized ISAR-CLOSURE trial: the comparison of vascular closure devices versus manual compression after femoral artery puncture. J Am Coll Cardiol. 2014;6411(B):B245.
6.
NikolskyEMehranRHalkinA. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;44(6):1200–1209.
7.
NarinsCR. Access strategies for peripheral arterial intervention. Cardiol J. 2009;16(1):88–97.
8.
NiceCTimmonsGBartholemewPUberoiR. Retro-grade vs. antegrade puncture for infra-inguinal angioplasty. Cardiovasc Intervent Radiol. 2003;26(4):370–374.
9.
GabrielMPawlaczykKWaliszewskiKKrasińskiZMajewskiW. Location of femoral artery puncture site and the risk of postcatheterization pseudoaneurysm formation. Int J Cardiol. 2007;120(2):167–171.
10.
KweonMBhamidipatyVHoldenAHillAA. Antegrade superficial femoral artery versus common femoral artery punctures for infrainguinal occlusive disease. J Vasc Interv Radiol. 2012;23(9):1160–1164.
11.
ThaiHMWeinstockBS. The Mynx Grip vascular closure device. Endovasc Today. 2012;4:28–33.
12.
ScheinertDSievertHTurcoMA. The safety and efficacy of an extravascular, water-soluble sealant for vascular closure: initial clinical results for Mynx. Catheter Cardiovasc Interv. 2007;70(5):627–633.
13.
BakerNLipinskiMEscarcegaR. TCT-844 active versus passive anchoring vascular closure devices: a safety and efficacy comparative analysis. J Am Coll Cardiol. 2014;64:B246(11 suppl B).
14.
SchmelterCLieblAPoullosNRuppertVVorwerkD. Suitability of Exoseal vascular closure device for antegrade femoral artery puncture site closure. Cardiovasc Intervent Radiol. 2013;36(3):659–668.
15.
MaxienDBehrendsBEberhardtKM. Evaluation of the 6-F ExoSeal vascular closure device in antegrade femoral artery punctures. J Endovasc Ther. 2012;19(6):836–843.
16.
HacklGGaryTBelajK. Exoseal for puncture site closure after antegrade procedures in peripheral arterial disease patients. Diagn Interv Radiol. 2014;20(5):426–431.
17.
MinkoPKatohMGräberSBueckerA. Obesity: an independent risk factor for insufficient hemostasis using the AngioSeal vascular closure device after antegrade puncture. Cardiovasc Intervent Radiol. 2012;35(4):775–778.
18.
LoobySKeelingANMcErleanAGivenMFGeogheganTLeeMJ. Efficacy and safety of the AngioSeal vascular closure device post antegrade puncture. Cardiovasc Intervent Radiol. 2008;31(3):558–562.
19.
GutzeitAvan SchieBSchochEHerganKGrafNBinkertCA. Feasibility and safety of vascular closure devices in an antegrade approach to either the common femoral artery or the superficial femoral artery. Cardiovasc Intervent Radiol. 2012;35(5):1036–1040.
20.
MarsoSPAminAPHouseJA; National Cardiovascular Data Registry. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA. 2010;303(21):2156–2164.
21.
WebberGWJangJGustavsonSOlinJW. Contemporary management of postcatheterization pseudoaneurysms. Circulation. 2007;115(20):2666–2674.
22.
SohailMRKhanAHHolmesDRJrWilsonWRSteckelbergJMBaddourLM. Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc. 2005;80(8):1011–1015.
